| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.11 MB | Adobe PDF |
Abstract(s)
A necessidade de opções contracetivas masculinas tornou-se mais premente devido à
mudança na dinâmica de género, à sensibilização crescente da responsabilidade
compartilhada no planeamento familiar e à mudança das expectativas sociais sobre os
papéis de género na saúde reprodutiva. Além disso, o crescente reconhecimento das
limitações dos métodos contracetivos femininos, incluindo os efeitos colaterais e o fardo
da contraceção que muitas vezes recai sobre as mulheres, incentivou o interesse em
soluções equitativas que envolveriam os homens na tomada de decisões reprodutivas. (1)
O objetivo desse estudo foi analisar os avanços recentes na contraceção masculina e as
opções que são mais promissoras para a aprovação no mercado. Adicionalmente, visa
correlacionar com os aspetos éticos, socioculturais bem como a aceitabilidade e perceção
pública.
Foram feitas pesquisas na plataforma da PubMed, Clinical Trials.gov e literatura
cinzenta. Deu-se preferência a artigos originais, de língua inglesa e publicados entre os
anos 2000 e 2024. Foram incluídos estudos em homens adultos do sexo masculino. Os
critérios de exclusão estabelecidos foram: estudos em população estritamente feminina,
estudos em animais, estudos não relacionados com o tema, estudos que abordam
patologia sistémica, estudos em transgéneros e artigos com texto integral não obtido.
Conclui-se que compostos como o DMAU e o gel de nestorona + testosterona, bem como
métodos não hormonais como o RISUG, apresentam elevado potencial clínico. Contudo,
barreiras socioculturais, ausência de financiamento sustentável e a invisibilidade do
tema nas agendas globais de saúde continuam a limitar o progresso. A análise sugere que
a implementação de políticas públicas, educação sexual inclusiva e uma mudança na
perceção social são essenciais para a viabilização prática de uma contraceção masculina
moderna e equitativa.
The need for new male contraceptive options has become more pressing due to changing gender dynamics, growing awareness of shared responsibility in family planning, and changing social expectations about gender roles in reproductive health. As more men express an interest in controlling their reproductive choices, the demand for nonpermanent and reversible male contraceptive methods has increased. Furthermore, growing recognition of the limitations of female contraceptive methods, including side effects and the burden of contraception that often falls on women, has encouraged interest in equitable solutions that involve men in reproductive decision-making. The aim of this thesis was to analyze recent advances in male contraception and the options that are most promising for market approval. Additionally, it aims to correlate with ethical and sociocultural aspects as well as public acceptability and perception. Research was done on the PubMed platform, Clinical Trials.gov and gray literature. Preference was given to original articles, in English and published between the years 2000 and 2024. Studies on adult men were included. The exclusion criteria established were studies on a strictly female population, studies on animals, studies unrelated to the topic, studies that address systemic pathology, studies on transgender people and articles with unobtainable full text. It is concluded that compounds such as DMAU and nestorone + testosterone gel, as well as non-hormonal methods such as RISUG, have high clinical potential. However, sociocultural barriers, lack of sustainable funding and the invisibility of the topic in global health agendas continue to limit progress. The analysis suggests that the implementation of public policies, inclusive sexuality education and a change in social perception are essential for the practical viability of modern and equitable male contraception.
The need for new male contraceptive options has become more pressing due to changing gender dynamics, growing awareness of shared responsibility in family planning, and changing social expectations about gender roles in reproductive health. As more men express an interest in controlling their reproductive choices, the demand for nonpermanent and reversible male contraceptive methods has increased. Furthermore, growing recognition of the limitations of female contraceptive methods, including side effects and the burden of contraception that often falls on women, has encouraged interest in equitable solutions that involve men in reproductive decision-making. The aim of this thesis was to analyze recent advances in male contraception and the options that are most promising for market approval. Additionally, it aims to correlate with ethical and sociocultural aspects as well as public acceptability and perception. Research was done on the PubMed platform, Clinical Trials.gov and gray literature. Preference was given to original articles, in English and published between the years 2000 and 2024. Studies on adult men were included. The exclusion criteria established were studies on a strictly female population, studies on animals, studies unrelated to the topic, studies that address systemic pathology, studies on transgender people and articles with unobtainable full text. It is concluded that compounds such as DMAU and nestorone + testosterone gel, as well as non-hormonal methods such as RISUG, have high clinical potential. However, sociocultural barriers, lack of sustainable funding and the invisibility of the topic in global health agendas continue to limit progress. The analysis suggests that the implementation of public policies, inclusive sexuality education and a change in social perception are essential for the practical viability of modern and equitable male contraception.
Description
Keywords
Contraceção Hormonal Contraceção Masculina Fatores Socioculturais Novos Métodos Contracetivos Perceção Pública Questões
Éticas
